Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
This trial was to examine the impact of everolimus and reduced dose of cyclosporine on
efficacy and safety compared to mycophenolate mofetil and a standard dose of cyclosporine in
heart transplant recipients.